Celgene Announces Oral GED0301 Phase 1b Results On Crohn's Disease

SUMMIT dpaAFX Celgene International Srl a whollyowned subsidiary of Celgene Corp. CELG announced that data from a randomized doubleblind multicenter exploratory phase 1b study evalu...